
    
      This is a non-randomized, non-interventional study that is part of the DREAM Study of Brigham
      and Women's Hospital. DREAM is led by Dr. Madhav Thambisetty, MD, PhD, Chief of the Clinical
      and Translational Neuroscience Section, Laboratory of Behavioral Neuroscience, National
      Institute on Aging (NIA) intramural research program. This study aims to evaluate the
      comparative risk of dementia/Alzheimer's disease onset between patients treated with
      medications that target specific metabolic pathways and patients treated with alternative
      medications for the same indication using healthcare claims data.
    
  